Decoy Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DCOY and other ETFs, options, and stocks.About DCOY
Decoy Therapeutics, Inc. is a preclinical-stage biotechnology company that is leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company is headquartered in Houston, TX.
CEOFrederick E. Pierce
CEOFrederick E. Pierce
Employees2
Employees2
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2020
Founded2020
Employees2
Employees2
DCOY Key Statistics
Market cap5.62M
Market cap5.62M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume12.38M
Average volume12.38M
High today$0.903
High today$0.903
Low today$0.85
Low today$0.85
Open price$0.90
Open price$0.90
Volume158.74K
Volume158.74K
52 Week high$49.50
52 Week high$49.50
52 Week low$0.5148
52 Week low$0.5148
Stock Snapshot
Decoy Therapeutics(DCOY) stock is priced at $0.88, giving the company a market capitalization of 5.62M. It carries a P/E multiple of -0.02.
As of 2026-01-20, Decoy Therapeutics(DCOY) stock has fluctuated between $0.85 and $0.90. The current price stands at $0.88, placing the stock +3.5% above today's low and -2.5% off the high.
The Decoy Therapeutics(DCOY)'s current trading volume is 158.74K, compared to an average daily volume of 12.38M.
In the last year, Decoy Therapeutics(DCOY) shares hit a 52-week high of $49.50 and a 52-week low of $0.51.
In the last year, Decoy Therapeutics(DCOY) shares hit a 52-week high of $49.50 and a 52-week low of $0.51.
People also own
Based on the portfolios of people who own DCOY. This list is generated using Robinhood data, and it’s not a recommendation.